Coordinated five consecutive TOPIC2INNO projects (2014-2021) delivering KAM/EIMC innovation management services to SMEs across Ile-de-France and French overseas territories.
CHAMBRE DE COMMERCE ET D'INDUSTRIE DE REGION PARIS ILE-DE-FRANCE
Paris regional chamber of commerce delivering Enterprise Europe Network SME innovation services and contributing business ecosystem expertise to diverse EU research consortia.
Their core work
CCI Paris Ile-de-France is the regional chamber of commerce serving the greater Paris area — one of the largest CCIs in Europe, representing hundreds of thousands of businesses. Within H2020, their primary role has been operating Enterprise Europe Network (EEN) services: helping SMEs access innovation support, technology transfer, and EU funding instruments. They also contribute business ecosystem expertise to research and technology projects spanning water sensing, manufacturing skills, border security, and health genomics, acting as a bridge between research consortia and the industrial fabric of the Paris region.
What they specialise in
All EEN projects plus participation in R2PI (circular economy policy) and FIT4FoF (workforce skills) demonstrate consistent focus on translating research outputs into SME-usable services.
Participated in PROTEUS (microfluidic water quality sensing), InForMed (micro-fabricated medical devices), and C-BORD (container inspection), contributing business validation or market access.
Third-party role in KNOWMAK and RISIS 2, providing data on firm innovation capabilities and STI indicators from the Paris business ecosystem.
Participation in GenoMed4ALL (2021-2025) on federated learning and multi-omics for haematological diseases marks a new direction into health AI.
How they've shifted over time
In the early period (2014-2018), CCI Paris built its H2020 presence around two parallel tracks: EEN innovation management for SMEs and participation in diverse technology projects (microfluidics, medical devices, border security, light pollution awareness). From 2019 onward, the EEN coordination role became more dominant and routine, while new participations shifted toward research policy intelligence (RISIS 2, STI indicators) and digital health (GenoMed4ALL with federated learning). The organization appears to be consolidating its core EEN role while selectively entering data-intensive domains where business ecosystem knowledge adds value.
CCI Paris is moving from broad technology project participation toward data-driven innovation policy and digital health, suggesting future interest in AI applications with clear business or public service relevance.
How they like to work
CCI Paris operates in a dual mode: they coordinate their own EEN service delivery projects (5 as coordinator) while joining larger research consortia as a partner or third party (11 projects). With 188 unique partners across 25 countries, they function as a network hub rather than a deep bilateral collaborator — typical for a chamber of commerce that connects many actors. Their third-party roles in RISIS 2 and KNOWMAK suggest they also contribute data and business intelligence without taking on heavy project management responsibilities.
Extensive pan-European network of 188 unique consortium partners across 25 countries, reflecting both their EEN mandate (which spans all EU member states) and diverse thematic project involvement. The geographic spread is broad with no single dominant partner country beyond France.
What sets them apart
CCI Paris Ile-de-France brings something most research organizations cannot: direct access to the largest regional business ecosystem in France, with institutional relationships spanning tens of thousands of companies. For consortium builders, this means a partner who can provide real-world market validation, SME engagement channels, and dissemination reach that academic or research partners typically lack. Their EEN track record also makes them a credible partner for any project requiring structured innovation management or technology transfer to industry.
Highlights from their portfolio
- PROTEUSLargest single EC contribution (EUR 625,625) for adaptive microfluidic water quality sensing — shows CCI's capacity to participate in serious technical R&D projects.
- GenoMed4ALLMost recent and forward-looking project (2021-2025), applying federated learning and multi-omics to haematological diseases — a significant pivot into health AI.
- TOPIC2INNO seriesFive consecutive coordination grants (2014-2021) for EEN innovation management services, demonstrating sustained institutional commitment and EC trust in their delivery capacity.